Research Article
[Retracted] DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer—A Study Based on TCGA Database
Table 3
Univariate analysis and multivariate analysis of the correlation of DNM1 expression with OS among CC patients.
| Characteristics | Total () | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | | Hazard ratio (95% CI) | |
| Age (>65 vs. ≤65) | 477 | 1.610 (1.052-2.463) | 0.028 | 2.366 (1.011-5.536) | 0.047 | Gender (male vs. female) | 477 | 1.101 (0.746-1.625) | 0.627 | | | T stage (T3 & T4 vs. T1 & T2) | 476 | 3.072 (1.423-6.631) | 0.004 | 0.730 (0.134-3.986) | 0.716 | N stage (N1 & N2 vs. N0) | 477 | 2.592 (1.743-3.855) | <0.001 | 0.153 (0.014-1.609) | 0.118 | M stage (M1 vs. M0) | 414 | 4.193 (2.683-6.554) | <0.001 | 3.022 (1.158-7.887) | 0.024 | Pathologic stage (Stage III & Stage IV vs. Stage I & Stage II) | 466 | 2.947 (1.942-4.471) | <0.001 | 17.160 (1.348-218.491) | 0.029 | Perineural invasion (yes vs. no) | 181 | 1.940 (0.982-3.832) | 0.056 | 0.979 (0.388-2.470) | 0.964 | Lymphatic invasion (yes vs. no) | 433 | 2.450 (1.614-3.720) | <0.001 | 1.318 (0.512-3.392) | 0.567 | DNM1 (high vs. low) | 477 | 1.725 (1.163-2.558) | 0.007 | 2.370 (0.859-6.536) | 0.096 |
|
|